Characterization of peptide aptamers targeting Bfl-1 anti-apoptotic protein

Biochemistry

Volumn 50, Issue 23, 2011, Pages 5120-5129

  Brien, G ^a,b,c   Debaud, A L ^a,c   Bickle, M ^d   Trescol Biemont M C ^a,b,c   Moncorge O ^d   Colas, P ^d   Bonnefoy Berard N ^a,b,e  

^a UNIVERSITÉ DE LYON   (France)

^b INSERM   (France)

^c UNIVERSITÉ LYON 1   (France)

^d Aptanomics   (France)

^e Protein Phosphorylation and Human Disease Group   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM COMPOUNDS; CELL CULTURE; CELL DEATH; LANTHANUM COMPOUNDS; MAMMALS; YEAST;

ANTI-APOPTOTIC PROTEIN; ANTIAPOPTOTIC ACTIVITIES; APOPTOTIC ACTIVITY; CHEMOTHERAPEUTIC AGENTS; INDUCED APOPTOSIS; NON-CONSTRAINED; THERAPEUTIC TARGETS; VARIABLE REGIONS;

PEPTIDES;

BCL2 RELATED PROTEIN A1; CISPLATIN; FLUDARABINE; PEPTIDE APTAMER; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG SENSITIVITY; DRUG SENSITIZATION; HELA CELL; HUMAN; HUMAN CELL; LYMPHOMA CELL; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; YEAST;

MAMMALIA;

EID: 79958836239     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi101839p     Document Type: Article

References (37)

1. Chonghaile, T. N. and Letai, A. (2008) Mimicking the BH3 domain to kill cancer cells Oncogene 27 (Suppl. 1) S149-S157
2. Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., Joseph, M. K., Kitada, S., Korsmeyer, S. J., Kunzer, A. R., Letai, A., Li, C., Mitten, M. J., Nettesheim, D. G., Ng, S., Nimmer, P. M., O'Connor, J. M., Oleksijew, A., Petros, A. M., Reed, J. C., Shen, W., Tahir, S. K., Thompson, C. B., Tomaselli, K. J., Wang, B., Wendt, M. D., Zhang, H., Fesik, S. W., and Rosenberg, S. H. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours Nature 435, 677-681 (Pubitemid 40825512)
3. Park, C. M., Bruncko, M., Adickes, J., Bauch, J., Ding, H., Kunzer, A., Marsh, K. C., Nimmer, P., Shoemaker, A. R., Song, X., Tahir, S. K., Tse, C., Wang, X., Wendt, M. D., Yang, X., Zhang, H., Fesik, S. W., Rosenberg, S. H., and Elmore, S. W. (2008) Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins J. Med. Chem. 51, 6902-6915
4. Shoemaker, A. R., Mitten, M. J., Adickes, J., Ackler, S., Refici, M., Ferguson, D., Oleksijew, A., O'Connor, J. M., Wang, B., Frost, D. J., Bauch, J., Marsh, K., Tahir, S. K., Yang, X., Tse, C., Fesik, S. W., Rosenberg, S. H., and Elmore, S. W. (2008) Activity of the Bcl-2 family inhibitor ABT-263 in a panel of small cell lung cancer xenograft models Clin. Cancer Res. 14, 3268-3277
5. Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., Roberts, L., Tahir, S. K., Xiao, Y., Yang, X., Zhang, H., Fesik, S., Rosenberg, S. H., and Elmore, S. W. (2008) ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor Cancer Res. 68, 3421-3428
6. Yecies, D., Carlson, N. E., Deng, J., and Letai, A. (2010) Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1 Blood 115, 3304-3313
7. Lin, X., Morgan-Lappe, S., Huang, X., Li, L., Zakula, D. M., Vernetti, L. A., Fesik, S. W., and Shen, Y. (2007) 'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737 Oncogene 26, 3972-3979 (Pubitemid 46884293)
8. Chen, S., Dai, Y., Harada, H., Dent, P., and Grant, S. (2007) Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation Cancer Res. 67, 782-791 (Pubitemid 46192219)
9. van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., Adams, J. M., Roberts, A. W., and Huang, D. C. (2006) The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized Cancer Cell 10, 389-399 (Pubitemid 44711953)
10. Feuerhake, F., Kutok, J. L., Monti, S., Chen, W., LaCasce, A. S., Cattoretti, G., Kurtin, P., Pinkus, G. S., de Leval, L., Harris, N. L., Savage, K. J., Neuberg, D., Habermann, T. M., Dalla-Favera, R., Golub, T. R., Aster, J. C., and Shipp, M. A. (2005) NF'B activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes Blood 106, 1392-1399 (Pubitemid 41129606)
11. Monti, S., Savage, K. J., Kutok, J. L., Feuerhake, F., Kurtin, P., Mihm, M., Wu, B., Pasqualucci, L., Neuberg, D., Aguiar, R. C., Dal Cin, P., Ladd, C., Pinkus, G. S., Salles, G., Harris, N. L., Dalla-Favera, R., Habermann, T. M., Aster, J. C., Golub, T. R., and Shipp, M. A. (2005) Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response Blood 105, 1851-1861 (Pubitemid 40731764)
12. Dave, S. S., Fu, K., Wright, G. W., Lam, L. T., Kluin, P., Boerma, E. J., Greiner, T. C., Weisenburger, D. D., Rosenwald, A., Ott, G., Muller-Hermelink, H. K., Gascoyne, R. D., Delabie, J., Rimsza, L. M., Braziel, R. M., Grogan, T. M., Campo, E., Jaffe, E. S., Dave, B. J., Sanger, W., Bast, M., Vose, J. M., Armitage, J. O., Connors, J. M., Smeland, E. B., Kvaloy, S., Holte, H., Fisher, R. I., Miller, T. P., Montserrat, E., Wilson, W. H., Bahl, M., Zhao, H., Yang, L., Powell, J., Simon, R., Chan, W. C., and Staudt, L. M. (2006) Molecular diagnosis of Burkitt's lymphoma N. Engl. J. Med. 354, 2431-2442
13. Brien, G., Trescol-Biemont, M. C., and Bonnefoy-Berard, N. (2007) Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis Oncogene 26, 5828-5832 (Pubitemid 47312815)
14. Colas, P. (2008) The eleven-year switch of peptide aptamers J. Biol. 7, 2
15. Colas, P., Cohen, B., Jessen, T., Grishina, I., McCoy, J., and Brent, R. (1996) Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2 Nature 380, 548-550 (Pubitemid 26110646)
16. Cohen, B. A., Colas, P., and Brent, R. (1998) An artificial cell-cycle inhibitor isolated from a combinatorial library Proc. Natl. Acad. Sci. U.S.A. 95, 14272-14277 (Pubitemid 28549357)
17. Buerger, C., Nagel-Wolfrum, K., Kunz, C., Wittig, I., Butz, K., Hoppe-Seyler, F., and Groner, B. (2003) Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cells J. Biol. Chem. 278, 37610-37621 (Pubitemid 37175284)
18. Nagel-Wolfrum, K., Buerger, C., Wittig, I., Butz, K., Hoppe-Seyler, F., and Groner, B. (2004) The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells Mol. Cancer Res. 2, 170-182 (Pubitemid 39030307)
19. Fabbrizio, E., Le Cam, L., Polanowska, J., Kaczorek, M., Lamb, N., Brent, R., and Sardet, C. (1999) Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity Oncogene 18, 4357-4363 (Pubitemid 29392376)
20. Butz, K., Denk, C., Fitscher, B., Crnkovic-Mertens, I., Ullmann, A., Schroder, C. H., and Hoppe-Seyler, F. (2001) Peptide aptamers targeting the hepatitis B virus core protein: A new class of molecules with antiviral activity Oncogene 20, 6579-6586 (Pubitemid 32980284)
21. Nauenburg, S., Zwerschke, W., and Jansen-Durr, P. (2001) Induction of apoptosis in cervical carcinoma cells by peptide aptamers that bind to the HPV-16 E7 oncoprotein FASEB J. 15, 592-594
22. Pamonsinlapatham, P., Hadj-Slimane, R., Raynaud, F., Bickle, M., Corneloup, C., Barthelaix, A., Lepelletier, Y., Mercier, P., Schapira, M., Samson, J., Mathieu, A. L., Hugo, N., Moncorge, O., Mikaelian, I., Dufour, S., Garbay, C., and Colas, P. (2008) A RasGAP SH3 peptide aptamer inhibits RasGAP-Aurora interaction and induces caspase-independent tumor cell death PLoS One 3, e2902
23. Chattopadhyay, A., Tate, S. A., Beswick, R. W., Wagner, S. D., and Ko Ferrigno, P. (2006) A peptide aptamer to antagonize BCL-6 function Oncogene 25, 2223-2233
24. Appert, A., Nam, C. H., Lobato, N., Priego, E., Miguel, R. N., Blundell, T., Drynan, L., Sewell, H., Tanaka, T., and Rabbitts, T. (2009) Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia Cancer Res. 69, 4784-4790
25. Nouvion, A. L., Thibaut, J., Lohez, O. D., Venet, S., Colas, P., Gillet, G., and Lalle, P. (2007) Modulation of Nr-13 antideath activity by peptide aptamers Oncogene 26, 701-710 (Pubitemid 46204249)
26. Estojak, J., Brent, R., and Golemis, E. A. (1995) Correlation of two-hybrid affinity data with in vitro measurements Mol. Cell. Biol. 15, 5820-5829
27. Bickle, M. B., Dusserre, E., Moncorge, O., Bottin, H., and Colas, P. (2006) Selection and characterization of large collections of peptide aptamers through optimized yeast two-hybrid procedures Nat. Protoc. 1, 1066-1091
28. Brien, G., Debaud, A. L., Robert, X., Oliver, L., Trescol-Biemont, M. C., Cauquil, N., Geneste, O., Aghajari, N., Vallette, F. M., Haser, R., and Bonnefoy-Berard, N. (2009) C-terminal residues regulate localization and function of the antiapoptotic protein Bfl-1 J. Biol. Chem. 284, 30257-30263
29. Zha, H., Aime-Sempe, C., Sato, T., and Reed, J. C. (1996) Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2 J. Biol. Chem. 271, 7440-7444 (Pubitemid 26107015)
30. D'Sa-Eipper, C. and Chinnadurai, G. (1998) Functional dissection of Bfl-1, a Bcl-2 homolog: Anti-apoptosis, oncogene-cooperation and cell proliferation activities Oncogene 16, 3105-3114 (Pubitemid 28318781)
31. Zhang, H., Cowan-Jacob, S. W., Simonen, M., Greenhalf, W., Heim, J., and Meyhack, B. (2000) Structural basis of BFL-1 for its interaction with BAX and its anti-apoptotic action in mammalian and yeast cells J. Biol. Chem. 275, 11092-11099 (Pubitemid 30212751)
32. Chen, L. N., Wang, Y., Ma, D. L., and Chen, Y. Y. (2006) Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression Apoptosis 11, 101-111 (Pubitemid 43151648)
33. Zhai, D., Jin, C., Shiau, C. W., Kitada, S., Satterthwait, A. C., and Reed, J. C. (2008) Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins Mol. Cancer Ther. 7, 1639-1646
34. Simmons, M. J., Fan, G., Zong, W. X., Degenhardt, K., White, E., and Gelinas, C. (2008) Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist Oncogene 27, 1421-1428 (Pubitemid 351317460)
35. Degenhardt, K., Sundararajan, R., Lindsten, T., Thompson, C., and White, E. (2002) Bax and Bak independently promote cytochrome C release from mitochondria J. Biol. Chem. 277, 14127-14134 (Pubitemid 34968024)
36. Olsson, A., Norberg, M., Okvist, A., Derkow, K., Choudhury, A., Tobin, G., Celsing, F., Osterborg, A., Rosenquist, R., Jondal, M., and Osorio, L. M. (2007) Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia Br. J. Cancer 97, 769-777 (Pubitemid 47396296)
37. Bardou, C., Borie, C., Bickle, M., Rudkin, B. B., and Colas, P. (2009) Peptide aptamers for small molecule drug discovery Methods Mol. Biol. 535, 373-388